SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-002427
Filing Date
2019-02-04
Accepted
2019-02-04 17:08:08
Documents
2
Period of Report
2019-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s002568x3_8k.htm 8-K 30281
2 EXHIBIT 10.1 s002568x3_ex10-1.htm EX-10.1 14762
  Complete submission text file 0001140361-19-002427.txt   46188
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 19564808
SIC: 2834 Pharmaceutical Preparations